Woodstock lowered its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 9.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,120 shares of the pharmacy operator’s stock after selling 2,290 shares during the period. Woodstock’s holdings in Walgreens Boots Alliance were worth $1,798,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. First Financial Bank increased its position in shares of Walgreens Boots Alliance by 28.6% in the fourth quarter. First Financial Bank now owns 3,600 shares of the pharmacy operator’s stock worth $306,000 after buying an additional 800 shares during the last quarter. New England Research & Management bought a new position in shares of Walgreens Boots Alliance during the fourth quarter worth about $360,000. Natixis Asset Management bought a new position in shares of Walgreens Boots Alliance during the third quarter worth about $423,000. Reynolds Capital Management increased its position in shares of Walgreens Boots Alliance by 40.0% in the fourth quarter. Reynolds Capital Management now owns 6,300 shares of the pharmacy operator’s stock worth $536,000 after buying an additional 1,800 shares during the last quarter. Finally, Blue Fin Capital increased its position in shares of Walgreens Boots Alliance by 0.7% in the fourth quarter. Blue Fin Capital now owns 8,314 shares of the pharmacy operator’s stock worth $708,000 after buying an additional 55 shares during the last quarter.

Walgreens Boots Alliance Inc (NASDAQ:WBA) traded up 2.36% during midday trading on Friday, reaching $80.84. 3,449,158 shares of the company traded hands. Walgreens Boots Alliance Inc has a 1-year low of $73.00 and a 1-year high of $97.30. The stock has a market capitalization of $87.21 billion and a P/E ratio of 19.68. The firm has a 50-day moving average of $82.87 and a 200-day moving average of $87.02.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Thursday, January 7th. The pharmacy operator reported $1.03 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.96 by $0.07. The company earned $29 billion during the quarter, compared to analysts’ expectations of $29.24 billion. The company’s revenue was up 48.5% compared to the same quarter last year. On average, analysts predict that Walgreens Boots Alliance Inc will post $4.48 earnings per share for the current year.

WBA has been the topic of a number of recent research reports. Vetr downgraded shares of Walgreens Boots Alliance from a “strong-buy” rating to a “buy” rating and set a $93.97 target price on the stock. in a research report on Wednesday, October 7th. Zacks Investment Research raised shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Tuesday, December 29th. Cowen and Company reduced their target price on shares of Walgreens Boots Alliance from $104.00 to $102.00 in a research report on Wednesday, October 21st. Evercore ISI raised shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $94.50 target price on the stock in a research report on Wednesday, January 6th. Finally, Jefferies Group reaffirmed a “hold” rating and issued a $90.00 target price (down from $95.00) on shares of Walgreens Boots Alliance in a research report on Tuesday, December 15th. Six equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Walgreens Boots Alliance currently has an average rating of “Buy” and a consensus target price of $96.86.

In related news, Director John Anthony Lederer bought 10,000 shares of the business’s stock in a transaction on Monday, November 2nd. The shares were bought at an average price of $84.88 per share, for a total transaction of $848,800.00. Following the completion of the purchase, the director now directly owns 20,000 shares of the company’s stock, valued at $1,697,600. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director William C. Foote sold 3,500 shares of Walgreens Boots Alliance stock in a transaction dated Wednesday, November 4th. The shares were sold at an average price of $88.36, for a total value of $309,260.00. Following the completion of the transaction, the director now owns 30,823 shares in the company, valued at approximately $2,723,520.28. The disclosure for this sale can be found here.

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand). In addition, the Company has investments in Guangzhou Pharmaceuticals Corporation and Nanjing Pharmaceutical Company Limited. The Company operates in around 25 countries, which include the wholesale and distribution network with over 340 distribution centers and more than 180,000 pharmacies, health centers and hospitals in 19 countries.

12 Month Chart for NASDAQ:WBA

Frustrated with your broker? Are you tired of paying high fees? Do you feel like you are getting ripped off by your stock broker? It's time for a change. Find out which brokerage is best for your personal trading style at the InvestorPlace Broker Center. Compare brokers at a glance in the InvestorPlace Broker Center (Click Here).

Receive News & Ratings for Walgreens Boots Alliance Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc and related companies with MarketBeat.com's FREE daily email newsletter.